Ad is loading...
EMOLX vs RNWHX
EMOLX vs RNWHX Comparison
Open Charts EMOLX vs RNWHX
Lord Abbett Emerging Markets Equity F3
Price$15.55
Change-$0.30 (-1.89%)
VolumeN/A
CapitalizationN/A
American Funds New World R5E
Price$79.57
Change-$1.82 (-2.24%)
VolumeN/A
CapitalizationN/A
EMOLX vs RNWHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
FUNDAMENTALS
Fundamentals
RNWHX has more cash in the bank: 64B vs. EMOLX (5.55M). EMOLX pays higher dividends than RNWHX: EMOLX (1.57) vs RNWHX (1.44). EMOLX was incepted earlier than RNWHX: EMOLX (3 years) vs RNWHX (9 years). EMOLX is a more actively managed with annual turnover of: 145.00 vs. RNWHX (32.00). EMOLX has a lower initial minimum investment than RNWHX: EMOLX (0) vs RNWHX (250). EMOLX annual gain was more profitable for investors over the last year : 15.21 vs. RNWHX (11.83).
| EMOLX | RNWHX | EMOLX / RNWHX | |
| Total Expense Ratio | N/A | N/A | - |
| Annual Report Gross Expense Ratio | N/A | N/A | - |
| Fund Existence | 3 years | 9 years | - |
| Gain YTD | 13.065 | 9.868 | 132% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 5.55M | 64B | 0% |
| Annual Yield % from dividends | 1.57 | 1.44 | 109% |
| Returns for 1 year | 15.21 | 11.83 | 129% |
| Returns for 3 years | N/A | 0.39 | - |
| Returns for 5 years | N/A | 15.41 | - |
| Returns for 10 years | N/A | N/A | - |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PJHRX | 37.57 | N/A | N/A |
| PGIM Jennison Health Sciences R | |||
| CSCAX | 29.70 | -0.11 | -0.38% |
| Cove Street Capital Small Cap Val Instl | |||
| GFFDX | 82.79 | -0.61 | -0.73% |
| Invesco Global Focus R5 | |||
| VADFX | 74.84 | -0.56 | -0.74% |
| Invesco Equally-Wtd S&P 500 R6 | |||
| VSFCX | 22.37 | -0.32 | -1.41% |
| Federated Hermes Clover Small Value C | |||